Investor profile
LifeArc Ventures has backed 7 European tech companies across 8 funding rounds between 2021 and 2026, joining rounds totalling €275M. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: LifeArc
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| GlycoEra | Switzerland | 1 | €114M |
| Maxion Therapeutics | UK | 2 | €81M |
| Exciva | Germany | 1 | €51M |
| Closed Loop Medicine | UK | 1 | €15M |
| Cumulus Neuroscience | Ireland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| GlycoEra | Series B | €114M | 2025-05 |
| Maxion Therapeutics | Series A | €66M | 2025-03 |
| Exciva | Series B | €51M | 2026-01 |
| Closed Loop Medicine |
| 1 |
| €6.9M |
| Oxcan | UK | 1 | €3.5M |
| Surgery Hero | UK | 1 | €2.9M |
| Series A |
| €15M |
| 2021-11 |
| Maxion Therapeutics | Series A | €15M | 2023-02 |
| Cumulus Neuroscience | Other | €6.9M | 2021-05 |
| Oxcan | Other | €3.5M | 2023-01 |
| Surgery Hero | Seed | €2.9M | 2022-11 |
